Humana Inc. $HUM Shares Acquired by Daiwa Securities Group Inc.

Daiwa Securities Group Inc. lifted its stake in shares of Humana Inc. (NYSE:HUM) by 10.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 37,675 shares of the insurance provider’s stock after buying an additional 3,580 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Humana were worth $9,650,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in the stock. Sound View Wealth Advisors Group LLC grew its position in shares of Humana by 3.5% during the fourth quarter. Sound View Wealth Advisors Group LLC now owns 1,060 shares of the insurance provider’s stock worth $272,000 after buying an additional 36 shares in the last quarter. CoreCap Advisors LLC boosted its holdings in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares during the period. Insigneo Advisory Services LLC boosted its holdings in Humana by 3.0% in the third quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after purchasing an additional 43 shares during the period. Columbus Macro LLC boosted its holdings in Humana by 5.5% in the fourth quarter. Columbus Macro LLC now owns 821 shares of the insurance provider’s stock worth $210,000 after purchasing an additional 43 shares during the period. Finally, Synovus Financial Corp boosted its holdings in Humana by 2.0% in the third quarter. Synovus Financial Corp now owns 2,278 shares of the insurance provider’s stock worth $593,000 after purchasing an additional 45 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

HUM stock opened at $349.85 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $42.00 billion, a price-to-earnings ratio of 37.42, a PEG ratio of 2.00 and a beta of 0.76. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $351.88. The stock’s fifty day moving average is $248.43 and its two-hundred day moving average is $232.40.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm’s quarterly revenue was up 23.5% compared to the same quarter last year. During the same period last year, the business posted $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. On average, research analysts predict that Humana Inc. will post 9 EPS for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio (DPR) is presently 37.86%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on HUM. Cantor Fitzgerald began coverage on shares of Humana in a report on Wednesday, May 20th. They issued an “overweight” rating for the company. Zacks Research raised shares of Humana from a “strong sell” rating to a “hold” rating in a report on Wednesday, May 13th. Truist Financial lifted their price objective on shares of Humana from $270.00 to $320.00 and gave the stock a “hold” rating in a report on Monday, June 1st. Sanford C. Bernstein reaffirmed an “outperform” rating and issued a $425.00 price objective on shares of Humana in a report on Wednesday. Finally, Seaport Research Partners downgraded shares of Humana to a “neutral” rating in a report on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, fourteen have issued a Hold rating and four have assigned a Sell rating to the stock. According to MarketBeat, Humana has an average rating of “Hold” and a consensus price target of $279.30.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.